- Home
- NWL vs HCM Comparison
NWL vs HCM Comparison
Compare NWL & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NWL
- HCM
- Stock Information
- Founded
- NWL 1903
- HCM 2000
- Country
- NWL United States
- HCM Hong Kong
- Employees
- NWL N/A
- HCM N/A
- Industry
- NWL Plastic Products
- HCM Biotechnology: Pharmaceutical Preparations
- Sector
- NWL Industrials
- HCM Health Care
- Exchange
- NWL Nasdaq
- HCM Nasdaq
- Market Cap
- NWL 2.4B
- HCM 2.8B
- IPO Year
- NWL N/A
- HCM N/A
- Fundamental
- Price
- NWL $6.29
- HCM $15.27
- Analyst Decision
- NWL Buy
- HCM
- Analyst Count
- NWL 8
- HCM 0
- Target Price
- NWL $7.31
- HCM N/A
- AVG Volume (30 Days)
- NWL 7.2M
- HCM 56.9K
- Earning Date
- NWL 10-24-2025
- HCM 08-07-2025
- Dividend Yield
- NWL 4.52%
- HCM N/A
- EPS Growth
- NWL N/A
- HCM N/A
- EPS
- NWL N/A
- HCM 0.53
- Revenue
- NWL $7,397,000,000.00
- HCM $602,197,000.00
- Revenue This Year
- NWL N/A
- HCM $2.73
- Revenue Next Year
- NWL $1.36
- HCM $17.33
- P/E Ratio
- NWL N/A
- HCM $5.59
- Revenue Growth
- NWL N/A
- HCM N/A
- 52 Week Low
- NWL $4.22
- HCM $11.51
- 52 Week High
- NWL $11.78
- HCM $21.50
- Technical
- Relative Strength Index (RSI)
- NWL 64.89
- HCM 41.85
- Support Level
- NWL $5.73
- HCM $14.75
- Resistance Level
- NWL $6.06
- HCM $16.30
- Average True Range (ATR)
- NWL 0.26
- HCM 0.27
- MACD
- NWL 0.07
- HCM -0.09
- Stochastic Oscillator
- NWL 98.44
- HCM 28.57
About NWL Newell Brands Inc.
Newell Brands Inc is an American consumer goods company with a strong portfolio of well-known brands, including Rubbermaid, Sharpie, Graco, Coleman, Rubbermaid Commercial Products, Yankee Candle, Paper Mate, FoodSaver, Dymo, EXPO, Elmer's, Oster, NUK, Spontex and Campingaz. The group is focused on delighting consumers by lighting up everyday moments. Its segments are Home and Commercial Solutions, Learning and Development, and Outdoor and Recreation. The group geographic areas are the United States, Canada, Europe, the Middle East and Africa, Asia Pacific, and Latin America.
About HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.